SCHEMBL3794233

SCHEMBL3794233

CCOc1ccc(Cl)cc1N

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.68
SMN1; SMN2 Q16637 3/20 0.56
HSD17B10 Q99714 2/20 0.56
USP2 O75604 2/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
CREBBP Q92793 1/20 0.54
ALDH1A1 P00352 5/20 0.53
KDM4E B2RXH2 4/20 0.52
HPGD P15428 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
CYP2D6 P10635 1/20 0.52
TSHR P16473 2/20 0.51
CYP3A4 P08684 3/20 0.50
POLB P06746 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenol SCHEMBL27591435 0.87 MAPT (0.55) MAPTSMN1; SMN2HSD17B10USP2NPC1
SCHEMBL363534 0.85 MAPT (0.66) MAPTSMN1; SMN2USP2ALDH1A1KDM4E
SCHEMBL315662 0.84 ALDH1A1 (0.66) MAPTSMN1; SMN2HSD17B10USP2NPC1
SCHEMBL3787403 0.83 MAPT (0.58) MAPTSMN1; SMN2USP2RAB9AALDH1A1
4-Phenoxyaniline SCHEMBL7039928 0.82 MAPT (0.64) MAPTSMN1; SMN2HSD17B10USP2NPC1
SCHEMBL2525158 0.81 TSHR (0.56) MAPTSMN1; SMN2RAB9AALDH1A1KDM4E
SCHEMBL29684402 0.79 HTR2C (0.52) MAPTSMN1; SMN2USP2ALDH1A1KDM4E
SCHEMBL358044 0.79 KDM1A (0.57) MAPTSMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL27633737 0.79 MAPT (0.50) MAPTSMN1; SMN2HSD17B10USP2NPC1
SCHEMBL360551 0.79 HTR2C (0.52) MAPTSMN1; SMN2USP2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3396028-B1 DIRECT ELECTROCHEMICAL SYNTHESIS OF DOPED CONDUCTIVE POLYMERS ON METAL ALLOYS BOEING CO (US) 2022-04-06 EP claimed
US-7211202-B2 Process to make a conductive composition of a fluorinated polymer which contains polyaniline ATOFINA (FR) 2007-05-01 US claimed
EP-1428857-B1 Process to make a conductive composition of a fluorinated polymer which contains polyaniline ARKEMA FRANCE (FR) 2007-01-31 EP claimed
US-6764617-B1 AND FERROMAGNETIC IRON OXIDE PARTICLES; ELECTROMAGNETIC SHIELDS; ACID RESISTANCE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS & SPACE ADMINISTRATION 2004-07-20 US claimed
US-5968417-A Conducting compositions of matter THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) 1999-10-19 US claimed
US-5415893-A Dispersion of electrically conductive particles in a dispersing medium DSM N.V. (NL) 1995-05-16 US claimed
US-4288362-A Monoazo pigments containing a quinazo linonylacetoacetanilide coupling component BAYER AKTIENGESELLSCHAFT (DE) 1981-09-08 US claimed
US-11577212-B2 Stimuli-responsive micro-reservoirs for release of encapsulants SAS Nanotechnologies Inc. (US) 2023-02-14 US disclosed
EP-3396028-B1 DIRECT ELECTROCHEMICAL SYNTHESIS OF DOPED CONDUCTIVE POLYMERS ON METAL ALLOYS BOEING CO (US) 2022-04-06 EP disclosed
CN-110249008-B Azo compound or salt thereof, and dye-based polarizing film, dye-based polarizing plate, and liquid crystal display device each containing the same 日本化药株式会社 2021-06-11 CN disclosed
EP-3823745-A1 STIMULI-RESPONSIVE MICRO-RESERVOIRS FOR RELEASE OF ENCAPSULANTS SAS Nanotechnologies LLC (US) 2021-05-26 EP disclosed
EP-3000807-B1 MERCAPTONICOTINIC ACID COMPOUND AND PREPARATION METHOD AND USE THEREOF ACAD OF MILITARY MEDICAL SCIENCES (CN) 2021-04-21 EP disclosed
EP-3475276-B1 THIAZOLE DERIVATIVES USEFUL AS MUTANT IDH1 INHIBITORS FOR TREATING CANCER US HEALTH (US) 2021-03-31 EP disclosed
US-4260540-A SPIN DYEING POLYACRYLONITRILE BAYER AKTIENGESELLSCHAFT (DE) 1981-04-07 US disclosed
US-4246401-A Axomethine pigments BAYER AKTIENGESELLSCHAFT (DE) 1981-01-20 US disclosed
US-4246267-A HYPOTENSIVE AGENTS SCIENCE UNION ET CIE (FR) 1981-01-20 US disclosed
US-4225489-A Heterocyclic azo dyes and pigments containing 4-quinazolinone moieties BAYER AKTIENGESELLSCHAFT (DE) 1980-09-30 US disclosed
EP-0008627-A2 Quinazoline derivatives, azo dyes derived from the quinazolines and their use as pigments BAYER AG (DE) 1980-03-19 EP disclosed
US-4150019-A COLORFAST, HEAT RESISTANT, MIGRATION HOECHST AKTIENGESELLSCHAFT (DE) 1979-04-17 US disclosed
US-4014863-A LACQUERS, PRINTING INKS, PAINTS BAYER AKTIENGESELLSCHAFT (DT) 1977-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11577212-B2 Stimuli-responsive micro-reservoirs for release of encapsulants ORAI1, CD44, VAPA MAPT 3648/4885SMN1; SMN2 3171/4885HSD17B10 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.